Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Harpoon Therapeutics, Inc. (HARP)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
23 Mar 2023
HUNT RONALD
Director, 10% Owner
Harpoon Therapeutics, Inc.
(HARP)
10,000
+100%
10,000
$1,000.00
$10,000,000.00
BUY
22 Sep 2021
Erbez Georgia
Chief Financial Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
19,215
+115%
10,300
$8.10
$83,430.01
SELL
1 Jul 2021
Wesche Holger
Chief Scientific Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
52,852
-15%
10,000
$14.00
$140,000.00
SELL
28 May 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
6,328,095
-0%
57,494
$20.63
$1,186,189.90
SELL
26 May 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
6,385,589
-0%
17,159
$20.22
$346,937.80
SELL
21 May 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
6,402,748
-0%
15,907
$20.18
$321,030.47
SELL
18 May 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
6,418,655
-0%
47,948
$20.49
$982,226.60
SELL
13 May 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
6,466,603
-0%
16,421
$20.05
$329,313.90
SELL
10 May 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
6,483,024
-1%
68,262
$21.04
$1,436,555.50
SELL
5 May 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
6,551,345
-0%
10,172
$22.52
$229,107.08
SELL
30 Apr 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
6,564,958
-4%
328,519
$22.48
$7,386,435.50
SELL
27 Apr 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
6,911,758
-1%
130,143
$21.99
$2,861,368.50
SELL
21 Apr 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
7,020,675
-0%
8,972
$18.97
$170,229.39
SELL
16 Apr 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
7,029,926
-0%
38,152
$19.04
$726,550.40
SELL
15 Apr 2021
MPM BioVentures 2014, L.P.
Former 10% Owner
Harpoon Therapeutics, Inc.
(HARP)
3,220,844
-0%
4,666
$20.16
$94,075.08
SELL
13 Apr 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
7,067,244
-0%
38,556
$20.16
$777,359.10
SELL
9 Apr 2021
MPM BioVentures 2014, L.P.
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
3,226,369
-0%
12,796
$23.15
$296,260.97
SELL
9 Apr 2021
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
7,112,900
-0%
30,928
$21.90
$677,357.10
SELL
1 Apr 2021
Wesche Holger
Chief Scientific Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
53,352
-15%
10,000
$20.45
$204,490.66
SELL
10 Feb 2021
MPM BioVentures 2014, L.P.
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
3,238,306
-5%
183,051
$20.00
$3,661,020.00
SELL
5 Feb 2021
MPM BioVentures 2014, L.P.
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
3,421,357
-2%
91,700
$20.06
$1,839,336.90
SELL
2 Feb 2021
MPM BioVentures 2014, L.P.
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
3,513,057
-3%
120,073
$20.22
$2,427,558.50
SELL
25 Jan 2021
MPM BioVentures 2014, L.P.
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
3,633,130
-16%
721,194
$20.02
$14,441,349.00
SELL
20 Jan 2021
MPM BioVentures 2014, L.P.
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
4,354,324
-1%
68,455
$22.51
$1,540,761.50
BUY
11 Jan 2021
New Leaf Ventures III, L.P.
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
913,860
+34%
235,294
$17.00
$3,999,998.00
BUY
11 Jan 2021
HUNT RONALD
Director, 10% Owner
Harpoon Therapeutics, Inc.
(HARP)
913,860
+34%
235,294
$17.00
$3,999,998.00
SELL
4 Jan 2021
Wesche Holger
Chief Scientific Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
59,752
-14%
10,000
$18.38
$183,836.88
SELL
1 Oct 2020
Wesche Holger
Chief Scientific Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
53,669
-15%
10,000
$16.27
$162,737.20
BUY
18 Aug 2020
Erbez Georgia
Chief Financial Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
8,915
+390%
7,098
$11.46
$81,336.80
BUY
31 Jul 2020
Erbez Georgia
Chief Financial Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
1,817
+100%
1,817
$10.92
$19,841.64
SELL
1 Jul 2020
Wesche Holger
Chief Scientific Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
52,669
-15%
10,000
$16.20
$161,989.00
SELL
27 May 2020
Arix Bioscience plc
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
2,193,704
-14%
378,655
$21.37
$8,091,070.00
SELL
18 May 2020
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-3%
1,522
$14.77
$22,478.57
SELL
12 May 2020
Wesche Holger
Chief Scientific Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
52,669
-2%
1,400
$14.09
$19,719.98
SELL
7 May 2020
Wesche Holger
Chief Scientific Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
52,669
-12%
7,350
$14.10
$103,640.81
SELL
1 May 2020
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-11%
5,826
$12.07
$70,301.18
SELL
28 Apr 2020
Wesche Holger
Chief Scientific Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
52,669
-2%
1,250
$14.05
$17,565.00
SELL
16 Apr 2020
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-3%
1,521
$12.05
$18,330.11
SELL
13 Apr 2020
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-9%
4,556
$12.06
$54,959.03
SELL
6 Apr 2020
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-2%
1,270
$12.00
$15,240.98
SELL
16 Mar 2020
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-3%
1,521
$12.00
$18,252.00
SELL
2 Mar 2020
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-11%
5,826
$14.68
$85,525.68
SELL
18 Feb 2020
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-3%
1,521
$15.00
$22,815.00
SELL
31 Jan 2020
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-11%
5,826
$13.90
$81,006.45
BUY
21 Jan 2020
Erbez Georgia
Chief Financial Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
6,700
+100%
6,700
$14.09
$94,417.74
SELL
16 Jan 2020
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-3%
1,521
$14.94
$22,724.96
SELL
2 Jan 2020
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-11%
5,826
$14.18
$82,600.45
SELL
2 Jan 2020
Wesche Holger
Chief Scientific Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
52,669
-15%
10,000
$14.40
$143,987.00
SELL
27 Dec 2019
Baeuerle Patrick
Director
Harpoon Therapeutics, Inc.
(HARP)
273,953
-24%
87,379
$15.98
$1,396,280.90
SELL
16 Dec 2019
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-3%
1,521
$17.02
$25,887.57
SELL
13 Dec 2019
Arix Bioscience plc
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
2,572,359
-1%
36,558
$17.01
$621,990.10
SELL
13 Dec 2019
Chin Mark
Director, 10% Owner
Harpoon Therapeutics, Inc.
(HARP)
2,572,359
-1%
36,558
$17.01
$621,990.10
SELL
6 Dec 2019
Arix Bioscience plc
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
2,608,917
-9%
283,202
$17.75
$5,025,686.00
SELL
6 Dec 2019
Chin Mark
Director, 10% Owner
Harpoon Therapeutics, Inc.
(HARP)
2,608,917
-9%
283,202
$17.75
$5,025,686.00
SELL
2 Dec 2019
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-11%
5,826
$17.98
$104,751.48
SELL
18 Nov 2019
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
46,754
-28%
18,252
$13.37
$243,964.00
SELL
1 Nov 2019
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-11%
5,826
$13.17
$76,701.62
SELL
14 Oct 2019
Sacks Natalie
Chief Medical Officer, Officer
Harpoon Therapeutics, Inc.
(HARP)
45,754
-34%
24,150
$13.24
$319,761.80
BUY
14 May 2019
McMahon Gerald PhD
President and CEO, Director, Officer
Harpoon Therapeutics, Inc.
(HARP)
3,000
+50%
1,000
$10.16
$10,157.30
BUY
8 May 2019
McMahon Gerald PhD
President and CEO, Director, Officer
Harpoon Therapeutics, Inc.
(HARP)
2,000
+100%
1,000
$10.56
$10,558.70
BUY
3 May 2019
McMahon Gerald PhD
President and CEO, Director, Officer
Harpoon Therapeutics, Inc.
(HARP)
1,000
+100%
1,000
$10.53
$10,530.00
BUY
12 Feb 2019
MPM BioVentures 2014, L.P.
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
4,274,425
+6%
248,476
$14.00
$3,478,664.00
BUY
12 Feb 2019
UBS Oncology Impact Fund L.P.
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
3,648,422
+7%
249,553
$14.00
$3,493,742.00
BUY
12 Feb 2019
New Leaf Ventures III, L.P.
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
2,242,839
+23%
428,571
$14.00
$5,999,994.00
BUY
12 Feb 2019
Arix Bioscience plc
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
2,892,119
+17%
428,571
$14.00
$5,999,994.00
BUY
12 Feb 2019
GADICKE ANSBERT
10% Owner
Harpoon Therapeutics, Inc.
(HARP)
7,922,847
+6%
498,029
$14.00
$6,972,406.00
BUY
9 Nov 2018
EVNIN LUKE
Director, 10% Owner
Harpoon Therapeutics, Inc.
(HARP)
4,524,425
+5%
250,000
$14.00
$3,500,000.00
BUY
9 Nov 2018
HUNT RONALD
Director, 10% Owner
Harpoon Therapeutics, Inc.
(HARP)
2,242,839
+23%
428,571
$14.00
$5,999,994.00
BUY
9 Nov 2018
Chin Mark
Director, 10% Owner
Harpoon Therapeutics, Inc.
(HARP)
2,892,119
+17%
428,571
$14.00
$5,999,994.00
Home